BDH Industries

Who are in the management team of BDH Industries?

As of March 2023, the management team of BDH Industries includes Jayashree Nair (Chairperson & Managing Director), S C Kachhara (Joint Managing Director & CFO), Karthika Nair (Director), and several independent directors, including Dinesh Variar, Bhagirath Singh Sihag, and Kairav Trivdi, along with Nikita Phatak (Company Secretary & Compliance Officer). This team oversees the company's operations and strategic direction.

As of March 2023, the management team of BDH Industries includes the following individuals:<BR><BR>1. Jayashree Nair - Chairperson & Managing Director<BR>2. S C Kachhara - Joint Managing Director & CFO<BR>3. Karthika Nair - Director<BR>4. Dinesh Variar - Independent Director<BR>5. Bhagirath Singh Sihag - Independent Director<BR>6. Nikita Phatak - Company Secretary & Compliance Officer<BR>7. Kairav Trivdi - Independent Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does BDH Industries do?

BDH Industries Ltd is a micro-cap pharmaceutical and biotechnology company that manufactures various drug formulations, primarily in the antibiotic, anti-inflammatory, and anti-microbial segments. As of March 2025, it reported net sales of 18 Cr and a net profit of 2 Cr, with a market cap of Rs 144 Cr.

Overview:<BR>BDH Industries Ltd is a pharmaceutical and biotechnology company engaged in the manufacturing of a wide range of drug formulations, primarily in the antibiotic, anti-inflammatory, and anti-microbial segments, classified as a micro-cap company.<BR><BR>History:<BR>Incorporated in 1990, BDH Industries was converted into a public limited company in 1994 after amalgamating with Bombay Drug House Pvt Ltd. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 18 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 2 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 144 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 16.00<BR>- Industry P/E: 35<BR>- Dividend Yield: 1.75%<BR>- Debt Equity: -0.37<BR>- Return on Equity: 14.60%<BR>- Price to Book: 2.33<BR><BR>Contact Details:<BR>Address: Nair Baug, Akurli Road Kandivli (E) Mumbai Maharashtra : 400101<BR>Tel: 91-22-28871370/28870834<BR>Email: comp.sec@bdhind.com<BR>Website: http://www.bdhind.com

Has BDH Industries declared dividend?

Yes, BDH Industries has declared a dividend of 45% (4.5 per share) with an ex-date of August 2, 2024. While recent returns have been negative, the company has shown significant growth over longer periods, with a total return of 328.51% over the past 5 years.

BDH Industries has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 45%<BR>- Amount per share: 4.5<BR>- Ex-date: 02 Aug 24<BR><BR>Dividend Yield: 1.75%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.29%, with no dividend return, resulting in a total return of -30.29%.<BR><BR>Over the past year, the price return was -25.9%, with a dividend return of 1.29%, leading to a total return of -24.61%.<BR><BR>In the 2-year period, the price return was 73.18%, accompanied by a dividend return of 5.60%, culminating in a total return of 78.78%.<BR><BR>For the 3-year period, the price return was 103.04%, with a dividend return of 11.42%, resulting in a total return of 114.46%.<BR><BR>In the last 4 years, the price return was 151.38%, with a dividend return of 13.95%, leading to a total return of 165.33%.<BR><BR>Over the past 5 years, the price return was 302.98%, with a dividend return of 25.53%, resulting in a total return of 328.51%.<BR><BR>Overall, BDH Industries has declared a significant dividend, and while the recent returns over shorter periods show negative performance, longer-term returns reflect substantial growth, particularly in price returns.

Who are the peers of the BDH Industries?

BDH Industries' peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Lactose (India), Welcure Drugs, Sotac Pharma, and Vaishali Pharma. Among these, Sun Pharma and Cipla show excellent management and growth, while Lactose (India) has the lowest 1-year return at -35.55%, compared to BDH Industries' -25.45%.

Peers: The peers of BDH Industries are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Lactose (India), Welcure Drugs, Sotac Pharma., and Vaishali Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, and BDH Industries, while Below Average management risk is found at Lactose (India), Welcure Drugs, Sotac Pharma., and Vaishali Pharma. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is noted for Divi's Lab., BDH Industries, Torrent Pharma, Lactose (India), and Vaishali Pharma. Excellent capital structure is seen at Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, and BDH Industries, while Below Average capital structure is present at Lactose (India), Welcure Drugs, and Vaishali Pharma.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Divi's Lab. at 51.69%, while the peer with the lowest is Lactose (India) at -35.55%. BDH Industries has a 1-year return of -25.45%, which is better than Lactose (India) but worse than Divi's Lab. Additionally, Lactose (India), BDH Industries, and Vaishali Pharma have negative six-month returns.

What is the technical trend for BDH Industries?

As of June 6, 2025, BDH Industries is in a bearish trend with moderate strength, supported by bearish MACD and moving averages, while mixed signals from KST and Bollinger Bands indicate a lack of clear direction.

As of 6 June 2025, the technical trend for BDH Industries has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. The weekly MACD is bearish, and daily moving averages confirm a bearish trend. While the monthly MACD is mildly bearish, the Bollinger Bands indicate a mildly bearish outlook on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, suggesting mixed signals. Overall, the lack of clear trends in Dow Theory and the absence of signals from the RSI further support the bearish sentiment.

Who are the top shareholders of the BDH Industries?

The top shareholders of BDH Industries are Jayashree Nair with 21.83%, Vramath Financial Services Pvt Ltd at 5.59%, and individual investors holding 29.02%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of BDH Industries include Jayashree Nair, who holds the highest promoter stake at 21.83%. The highest public shareholder is Vramath Financial Services Pvt Ltd, with a holding of 5.59%. Additionally, individual investors collectively own 29.02% of the company. There is also one Foreign Institutional Investor (FII) that holds 0.28% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

How big is BDH Industries?

As of 24th July, BDH Industries Ltd has a market capitalization of 188.00 Cr, with recent net sales of 21.20 Cr and a net profit loss of 0.00 Cr. Shareholder's funds are at 68.76 Cr, and total assets amount to 86.94 Cr.

As of 24th July, BDH Industries Ltd has a market capitalization of 188.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest two quarters, BDH Industries reported Net Sales of 21.20 Cr. The Net Profit for the same period was recorded as a loss of 0.00 Cr.<BR><BR>The latest annual reporting period shows Shareholder's Funds at 68.76 Cr and Total Assets amounting to 86.94 Cr.

How has been the historical performance of BDH Industries?

BDH Industries has experienced a decline in net sales and profitability, with net sales dropping to 66.51 Cr in March 2025 from 85.83 Cr in March 2024. However, cash flow from operating activities improved to 14.00 Cr in March 2025, recovering from a negative cash flow the previous year.

Answer:<BR>The historical performance of BDH Industries shows a fluctuating trend in net sales and profitability over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>BDH Industries reported net sales of 66.51 Cr in March 2025, down from 85.83 Cr in March 2024 and 74.46 Cr in March 2023, indicating a downward trend in revenue. The total operating income mirrored this decline, falling to 66.51 Cr in March 2025 from 85.83 Cr in the previous year. The company's total expenditure also decreased to 54.90 Cr in March 2025, compared to 73.41 Cr in March 2024. Operating profit (PBDIT) was 13.45 Cr in March 2025, slightly lower than 14.00 Cr in March 2024, while profit before tax decreased to 12.47 Cr from 13.25 Cr. Profit after tax showed a similar trend, with 9.27 Cr in March 2025 compared to 9.87 Cr in March 2024. The company's total assets decreased to 86.94 Cr in March 2025 from 93.41 Cr in March 2024, and total liabilities also fell to 86.94 Cr from 93.41 Cr. Cash flow from operating activities improved to 14.00 Cr in March 2025, recovering from a negative cash flow of -1.00 Cr in March 2024, while the closing cash and cash equivalents increased to 31.00 Cr from 25.00 Cr. Overall, BDH Industries has experienced fluctuations in its financial metrics, with a recent decline in sales and profits but an improvement in cash flow.

Is BDH Industries overvalued or undervalued?

As of December 3, 2025, BDH Industries is fairly valued with a PE ratio of 21.85 and an EV to EBIT of 15.88, showing a strong long-term performance of 340.74% over five years, despite a recent dip of -12.74% compared to the Sensex.

As of 3 December 2025, BDH Industries has moved from an expensive to a fair valuation grade. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 21.85, an EV to EBIT of 15.88, and a ROCE of 32.27%. <BR><BR>In comparison to its peers, BDH Industries' PE ratio aligns closely with Cipla's at 22.39, while it is notably lower than Sun Pharma's expensive valuation at 37.51. Additionally, BDH's EV to EBITDA of 14.69 is more favorable compared to the higher ratios of its competitors, indicating a more attractive valuation. Despite a recent dip in stock performance compared to the Sensex, where BDH returned -12.74% over the past month against the Sensex's 1.34%, its long-term performance remains strong with a 340.74% return over five years.

Are BDH Industries Ltd latest results good or bad?

BDH Industries Ltd's latest quarterly results are strong, with record revenue and profit, but the annual revenue decline raises concerns about sustainability. Investors should be cautious and monitor future developments.

BDH Industries Ltd's latest results present a mixed picture. On one hand, the company achieved a record quarterly revenue of ₹29.34 crores and a net profit of ₹3.49 crores in Q3 FY26, marking the highest figures ever recorded for the company. This indicates strong operational momentum and improved efficiency, particularly as the net profit reflects a 33.21% increase compared to the previous quarter.<BR><BR>However, when looking at the annual performance for FY25, the company faced challenges, with revenues declining by 22.4% year-on-year to ₹66.00 crores. Despite maintaining net profit at ₹9.00 crores, the significant drop in revenue raises concerns about the sustainability of the recent quarterly gains.<BR><BR>The company's return on equity (ROE) stands at a solid 15.54%, indicating effective capital utilization, and it operates with a zero-debt balance sheet, which provides financial flexibility. Nevertheless, the high price-to-earnings (P/E) ratio of 24x suggests that the stock may be in an expensive territory relative to its growth prospects.<BR><BR>In summary, while the latest quarterly results are strong and indicate positive operational trends, the annual decline in revenue casts a shadow over the overall performance, suggesting that investors should approach with caution and monitor future developments closely.

When is the next results date for BDH Industries Ltd?

The next results date for BDH Industries Ltd is 21 May 2026.

The next results date for BDH Industries Ltd is scheduled for 21 May 2026.

Should I buy, sell or hold BDH Industries Ltd?

Why is BDH Industries Ltd falling/rising?

As of 02-Jun, BDH Industries Ltd's stock price is declining, currently at 351.45, down 4.45%. The stock has underperformed its sector and shows negative trends over various periods, indicating a bearish outlook and decreased investor confidence.

As of 02-Jun, BDH Industries Ltd's stock price is falling, currently at 351.45, which reflects a decrease of 16.35 or 4.45%. The stock has underperformed its sector by 3.87% today and opened with a loss of 2.09%. It reached an intraday low of 351.05, marking a decline of 4.55%. <BR><BR>The stock's performance over various periods shows a negative trend, with a 1-week decline of 2.17%, a 1-month drop of 6.86%, and a year-to-date decrease of 17.39%. Additionally, BDH Industries is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. <BR><BR>Investor participation has also decreased significantly, with delivery volume on June 1 falling by 52.91% compared to the 5-day average. This decline in trading activity suggests a lack of confidence among investors, contributing to the stock's falling price. Overall, these factors collectively indicate why BDH Industries Ltd is experiencing a decline in its stock price.

Which are the latest news on BDH Industries?